BOSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. INZY(“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that it will host an Investor and Analyst Event on Tuesday, September 26, 2023 at 8:00…Read More
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep 26 2023 Inozyme Pharma NASDAQINZY
